Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Telix Pharmaceuticals (innovations) Pty Ltd

Clinical trials sponsored by Telix Pharmaceuticals (innovations) Pty Ltd, explained in plain language.

Now part of Telix Pharmaceuticals Limited TLX ASX

Subsidiary of Telix, a radiopharmaceutical company developing targeted radiation therapies.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Terminated 1

Promising prostate cancer treatment trial halted early

Disease control Terminated

This phase 3 study tested a radioactive antibody called 177Lu-DOTA-rosopatamab combined with standard care for men with metastatic castration-resistant prostate cancer that had progressed after hormone therapy. The goal was to see if the combination slowed cancer growth or improv…

Phase: PHASE3 • Sponsor: Telix Pharmaceuticals (Innovations) Pty Ltd • Aim: Disease control

Last updated Jun 27, 2026 09:07 UTC